Pharmacoepidemiology and Drug Safety

Cover image for Pharmacoepidemiology and Drug Safety

December 2000

Volume 9, Issue 7

Pages 549–630

  1. Original Report

    1. Top of page
    2. Original Report
    3. Editorial
    4. Original Report
    5. Statement
    6. Editorial
    7. Original Report
    8. ISPE Commentary
    9. Current Awareness
    1. Postmarketing surveillance of medications and pregnancy outcomes: Clarithromycin and birth malformations (pages 549–556)

      Carol R. Drinkard, Deborah Shatin and Jon Clouse

      Article first published online: 2 FEB 2001 | DOI: 10.1002/pds.538

    2. A pharmacodynamic assessment of the impact of antihypertensive non-adherence on blood pressure control (pages 557–563)

      Peter W. Choo, Cynthia S. Rand, Thomas S. Inui, Mei-Ling Ting Lee, Claire Canning and Richard Platt

      Article first published online: 2 FEB 2001 | DOI: 10.1002/pds.539

  2. Editorial

    1. Top of page
    2. Original Report
    3. Editorial
    4. Original Report
    5. Statement
    6. Editorial
    7. Original Report
    8. ISPE Commentary
    9. Current Awareness
  3. Original Report

    1. Top of page
    2. Original Report
    3. Editorial
    4. Original Report
    5. Statement
    6. Editorial
    7. Original Report
    8. ISPE Commentary
    9. Current Awareness
    1. Co-morbidity of ‘Clinical Trial’ versus ‘Real-World’ patients using cardiovascular drugs (pages 569–579)

      Nicolien F. Wieringa, Rein Vos, Ger Th. Van Der Werf, Willem Jan Van Der Veen and Pieter A. De Graeff

      Article first published online: 2 FEB 2001 | DOI: 10.1002/pds.541

  4. Statement

    1. Top of page
    2. Original Report
    3. Editorial
    4. Original Report
    5. Statement
    6. Editorial
    7. Original Report
    8. ISPE Commentary
    9. Current Awareness
  5. Editorial

    1. Top of page
    2. Original Report
    3. Editorial
    4. Original Report
    5. Statement
    6. Editorial
    7. Original Report
    8. ISPE Commentary
    9. Current Awareness
    1. Is confused thinking the cause of a non-existent dilemma? Current worries about patient confidentiality and epidemiological research (pages 587–589)

      Liselotte Von Ferber, Hugh McGavock and Christian Von Ferber

      Article first published online: 2 FEB 2001 | DOI: 10.1002/pds.542

  6. Original Report

    1. Top of page
    2. Original Report
    3. Editorial
    4. Original Report
    5. Statement
    6. Editorial
    7. Original Report
    8. ISPE Commentary
    9. Current Awareness
    1. Short-term safety and tolerability of antihypertensive agents in Korean patients: an observational study (pages 603–609)

      Young Sik Kim, Hye Soon Park, Sung Sunwoo, Jai Jun Byeon, Yun Mi Song, Hong Gwan Seo, Cheol Hwan Kim, Kyeong Soo Cheon, Sun Mi Yoo and Jung Kwon Lee

      Article first published online: 2 FEB 2001 | DOI: 10.1002/pds.554

  7. ISPE Commentary

    1. Top of page
    2. Original Report
    3. Editorial
    4. Original Report
    5. Statement
    6. Editorial
    7. Original Report
    8. ISPE Commentary
    9. Current Awareness
    1. Pharmacoepidemiology in developing countries — what can ISPE do? (pages 611–613)

      Faranak Ansari PharmD

      Article first published online: 2 FEB 2001 | DOI: 10.1002/pds.545

  8. Current Awareness

    1. Top of page
    2. Original Report
    3. Editorial
    4. Original Report
    5. Statement
    6. Editorial
    7. Original Report
    8. ISPE Commentary
    9. Current Awareness
    1. Current Awareness (pages 615–630)

      Article first published online: 2 FEB 2001 | DOI: 10.1002/pds.493

SEARCH

SEARCH BY CITATION